Current Alzheimer Research

Papers
(The TQCC of Current Alzheimer Research is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Construction of lncRNA-ceRNA Networks to Reveal the Potential Role of Lfng/Notch1 Signaling Pathway in Alzheimer’s Disease25
Anthocyanidins Intake is Associated with Alzheimer’s Disease Risk in Americans over 60 Years of Age: Data from NHANES 2007-2008, 2009-2010, and 2017-201822
Recent Updates on Alzheimer’s Disease: Pathogenesis, Pathophysiology, Molecular Approaches and Natural Bioactive Compounds Used in Contemporary Time to Alleviate Disease21
Human microRNA-4433 (hsa-miR-4443) Targets 18 Genes to be a Risk Factor of Neurodegenerative Diseases21
Multi-Target Directed Ligands (MTDLs): Promising Coumarin Hybrids for Alzheimer’s Disease18
A Timeline of Ca2+/cAMP Signalling: From Basic Research to Potential Therapeutics for Dementia18
Comparative Bioavailability Study of a Novel Multi-Day Patch Formulation of Rivastigmine (Twice Weekly) with Exelon® Transdermal Patch (Daily)- A Randomized Clinical Trial16
Serine Racemase Expression Differentiates Aging from Alzheimer’s Brain15
Early Memory Impairment is Accompanied by Changes in GluA1/ p-GluA1 in APP/PS1 Mice14
Blood Neurofilament Light Chain in Different Types of Dementia14
Associations between Physical Performance Tests with Cognitive Changes: The Moderating Effect of Cognitive Status14
Microglia PTK2B/Pyk2 in the Pathogenesis of Alzheimer’s Disease14
Current Progress on Central Cholinergic Receptors as Therapeutic Targets for Alzheimer's Disease13
Development and Psychometric Validation of the 27 Item Zarit Caregiver Interview for Alzheimer’s Disease (ZCI-AD-27)13
Analysis of Alzheimer's Disease-Related Mortality Rates Among the Elderly Populations Across the United States: An Analysis of Demographic and Regional Disparities from 1999 to 202012
Effects of the Recurrent and Different Doses of Ketamine Exposure on Anxiety-like Behaviors and Locomotor Activity in Juvenile Rats12
Acknowledgements to Reviewers12
Low Intensity Electromagnetic Fields Act via Voltage-Gated Calcium Channel (VGCC) Activation to Cause Very Early Onset Alzheimer’s Disease: 18 Distinct Types of Evidence12
Trafficking of Muscarinic 1 Acetylcholine Receptor Regulated by VPS35 in Alzheimer's Disease12
Metabolic Syndrome, Alzheimer’s Disease, and Covid 19: A Possible Correlation12
Effects of the Co-occurrence of Diabetes Mellitus and Tooth Loss on Cognitive Function11
Glial-derived Neuroinflammation induced with Amyloid-beta-peptide Plus Fibrinogen Injection in Rat Hippocampus11
Acupuncture Improves Synaptic Plasticity of SAMP8 Mice through the RhoA/ROCK Pathway11
Cognitive Assessment of Dementia: The Need for an Inclusive Design Tool11
Artificial Intelligence in Eye Movements Analysis for Alzheimer’s Disease Early Diagnosis11
The Association of Allergy-Related and Non-Allergy-Related Olfactory Impairment with Cognitive Function in Older Adults: Two Cross- Sectional Studies10
Multifunctional Tasks and an Energy Crisis are Crucial Players in Determining the Vulnerability of the Entorhinal Cortex to Early Damage in Alzheimer’s Disease10
Retraction Notice: Optimized Turmeric Extract Reduces β-Amyloid and Phosphorylated Tau Protein Burden in Alzheimer's Transgenic Mice10
Imagine Yourself Dancing Waltz: The Effect of Imagination on Memory in Alzheimer’s Disease10
Influence of Inflammation, Gut Microbiota, and Stress on Cognition and Oral Health Therapies9
The Framework for an Integrative Theory of Alzheimer’s Disease9
Associations Between Metabolomics Findings and Brain Hypometabolism in Mild Cognitive Impairment and Alzheimer’s Disease9
Mapping the Connection Between Circadian Rhythms, Metabolism, and Neurodegeneration: Exploring Therapeutic Strategies9
Diversity and Regulation of Astrocyte Neurotoxicity in Alzheimer's Disease9
Radio-Anatomical Assessment of Cerebellum Volume in Individuals with Alzheimer's Disease9
Amisulpride Decreases Tau Protein Hyperphosphorylation in the Brain of OXYS Rats9
Roles of Microglia in AD Pathology9
Landmark Model-based Individual Dynamic Prediction of Conversion from Mild Cognitive Impairment to Alzheimer’s Disease using Cognitive Screening9
The Importance of Long-term Partner Observation in Cognitive Evaluation: A Very Early Creutzfeldt-Jakob Disease in a Patient with Mild Cognitive Impairment9
The Interaction of Dynamic Cerebral Autoregulation and Neurovascular Coupling in Cognitive Impairment8
Proposed Therapeutic Strategy to Combat Alzheimer’s Disease by Targeting Beta and Gamma Secretases8
Alzheimer’s Disease-Related Psychosis: An Overview of Clinical Manifestations, Pathogenesis, and Current Treatment8
Pharmacological Attributes of Fenugreek with Special Reference to Alzheimer’s Disease8
Evaluation and Characterization of Modified K114 Method to Localize Plaques in Rodent and Plaques and Tangles in Human Brain Tissue8
Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer’s Disease: Nexus of Cholinergic and Nerve Growth Factor Dysfunction8
Research Progress of Mitophagy in Alzheimer's Disease8
Vascular Lesions and Brain Atrophy in Alzheimer’s, Vascular and Mixed Dementia: An Optimized 3T MRI Protocol Reveals Distinctive Radiological Profiles8
Comprehensive Insights into Pathophysiology of Alzheimer's Disease: Herbal Approaches for Mitigating Neurodegeneration7
Therapeutic Effects of Arctiin on Alzheimer's Disease-like Model in Rats by Reducing Oxidative Stress, Inflammasomes and Fibrosis7
Research Progress of Eye Movement Analyses and its Detection Algorithms in Alzheimer’s Disease7
Alzheimer's Disease and Vascular Dementia, Connecting and Differentiating Features7
Does the Global Postural Re-Education Affect the Psychological and Postural Aspects of Alzheimer Disease Patients? A Six Months Quasi-Experimental Study7
A Brief Comparative Look at Experimental Memory Editing Techniques for Cognitive Dysfunction7
Microglial Modulation in Alzheimer’s Disease: Central Players in Neuroinflammation and Pathogenesis7
Hybrid PET/MRI with Flutemetamol and FDG in Alzheimer's Disease Clinical Continuum7
Environmental Enrichment and Metformin Combination Improves Cognitive Function through BDNF and HPA Axis in Chronically Stressed Rats7
Olfactory Function, Genetic Predisposition, and Cognitive Performance in Chinese Adults7
Common Neuropsychiatric Symptoms in Alzheimer’s Disease, Mild Cognitive Impairment, and Subjective Memory Complaints: A Unified Framework7
Climate Change and Global Warming: Are Individuals with Dementia - Including Alzheimer’s Disease - At a Higher Risk?7
Disruptions of Gut Microbiota are Associated with Cognitive Deficit of Preclinical Alzheimer's Disease: A Cross-Sectional Study7
Evidence of Clinical Efficacy and Pharmacological Mechanisms of Resveratrol in the Treatment of Alzheimer’s Disease7
Lithium Chloride Improves Electrophysiological and Memory Deficits in Rats with Streptozotocin-Induced Alzheimer's Disease7
Effects of Metformin on Modulating the Expression of Brain-related Genes of APP/PS1 Transgenic Mice based on Single Cell Sequencing6
White Matter Damage in Alzheimer’s Disease: Contribution of Oligodendrocytes6
History of Senile Dementia from the Antiquity to the Beginning of the Modern Age6
ceRNA Network Analysis Reveals AP-1 Transcription Factor Components as Potential Biomarkers for Alzheimer’s Disease6
Acknowledgements to Reviewers6
Prospective Memory in Mobile: Using Smartphone-Based Calendars to Rehabilitate Prospective Memory in Patients with Alzheimer’s Disease6
Kappa/Lambda light-chain typing in Alzheimer’s Disease6
Identification of MicroRNA Drug Targets for Alzheimer's and Diabetes Mellitus Using Network Medicine6
The Postoperative Effects of Anesthesia Exposure on Cognitive Decline in Older Adults: A Narrative Review6
Uncovering the Impact of Aggrephagy in the Development of Alzheimer's Disease: Insights Into Diagnostic and Therapeutic Approaches from Machine Learning Analysis6
Is the Alzheimer's Disease Assessment Scale-Cognitive Subscale Useful in Screening for Mild Cognitive Impairment and Alzheimer's Disease? A Systematic Review5
Complex Processes Underlying the Dynamic Changes of D-serine Levels in AD Brains5
Gastrointestinal Changes and Alzheimer's Disease5
Association Between Cannabis Use and Subjective Cognitive Decline: Findings from the Behavioral Risk Factor Surveillance System (BRFSS)5
Effect of Simultaneous Dual-Task Training on Regional Cerebral Blood Flow in Older Adults with Amnestic Mild Cognitive Impairment5
Prenatal Exposure to the 1944-45 Dutch Famine and Risk for Dementia up to Age 75: An Analysis of Primary Care Data5
Associations of Multimorbidity with Cerebrospinal Fluid Biomarkers for Neurodegenerative Disorders in Early Parkinson's Disease: A Crosssectional and Longitudinal Study5
Application of Diffusion Tensor Imaging Based on Automatic Fiber Quantification in Alzheimer's Disease5
Control of β-Site Amyloid Precursor Protein-Cleaving Enzyme-1 Expression by Protein Kinase C-λ/ι and Nuclear Factor κ-B5
Age- and Genotype-Dependent Effects of Chronic Nicotine on Presenilin1/2 Double Knockout Mice: From Behavior to Molecular Pathways5
Post-Hoc Assessment of Cognitive Efficacy in Alzheimer’s Disease Using a Latent Growth Mixture Model in AMBAR, a Phase 2B Randomized Controlled Trial5
Serum Biomarkers of Vascular Dysfunction, Neuropsychiatric Symptoms, and Clinical Severity of Alzheimer’s Disease: A Cross-sectional Study5
Assessment of the Inhibition of AChE and BChE by Carthamus caeruleus Essential Oil and Carline Oxide: Neuroprotective Effects and In Vivo Toxicity Assessment for the Management of Alzheimer’s Disease5
Microglial Circadian Rhythms and Neurodegenerative Diseases5
The Immunopathy of Alzheimer’s Disease: Innate or Adaptive?5
Temporal Speech Parameters Detect Mild Cognitive Impairment in Different Languages: Validation and Comparison of the Speech-GAP Test® in English and Hungarian5
Exploring Potential of Nano-formulations in the Treatment of Alzheimer’s Disease through Nasal Route5
Effects of Cycloastragenol on Alzheimer's Disease in Rats by Reducing Oxidative Stress, Inflammation, and Apoptosis5
0.081799983978271